Connect with us

Health News

Johnson & Johnson Files For European Approval Of Ebola Vaccine

Published

on

Johnson & Johnson Files For European Approval Of Ebola Vaccine

In less than a month after the European Medicines Agency (EMA) recommended approval of Merck & Co Inc’s vaccine, Johnson & Johnson has on Thursday said it had filed for approval from European regulators for its two-dose experimental vaccine to protect against Ebola.

READ:  Mugabe Body Arrives Home, In Zimbabwe

The company said it submitted two marketing authorization applications to the agency for its vaccine regimen targeting the Zaire strain of the Ebola virus, which most commonly causes outbreaks of the deadly disease.

J&J’s vaccine requires two injections administered about eight weeks apart, the first developed using J&J’s technology and the second from Denmark-based biotech Bavarian Nordic A/S.

READ:  Study Finds TB Prevention Course And First-Line Medicines For HIV

Since the Ebola outbreak in August 2018,  more than 2,000 persons have been killed , second only to the 2013-16 outbreak in West Africa that killed more than 11,300.

READ:  Burkina Faso Convicts Two Generals Over 2015 Coup

In the Democratic Republic of the Congo where Merck’s vaccine is already in use, health authorities are introducing J&J’s vaccine to counter the current outbreak in the eastern provinces of the country.

Health News

Rollout Of Johnson & Johnson Ebola Vaccine Begins In Congo

Published

on

By

Rollout Of Johnson & Johnson Ebola Vaccine Begins In Congo

The first Ebola vaccine was approved just this week, but aid group MSF has announced that health authorities in eastern Congo have introduced a new one produced by Johnson and Johnson.  The group says this is meant to help combat the world’s second worst outbreak of the virus on record.

READ:  ANN News At 5 - August 20, 2018

The new vaccine has passed clinical trials but has never been tested in a real-world setting.  MSF says it will be administered to fifty thousand persons in Goma, a city of two million residents on the Rwandan border.

MSF says the introduction of a second vaccine is not meant to replace Merck’s vaccine approved this week.  Johnson and Johnson, which is leading the project for MSF, says it’s vaccine is meant to complement the one by Merck and to provide an additional tool in the fight against future Ebola outbreaks.

READ:  Kazakh Military Helicopter With 13 People On Board Crashes - Defence Ministry

Some Congolese health officials have criticized the Johnson and Johnson vaccine on the grounds that it has not been properly tested.   But it has passed the first two phases of clinical trials, and has been endorsed by the World Health Organization.

READ:  Nigeria's Buhari To Face Political Heavyweight Opponent In Re-election Bid

Continue Reading

Health News

Merck Wins European Approval For World’s First-Ever Ebola Vaccine

Published

on

By

Merck Wins European Approval For World's First-Ever Ebola Vaccine

In a major step in the fight against Ebola, the World Health Organization (WHO) has approved the world’s first ever vaccine against the virus disease.

Merck pharmaceuticals manufactured the drug, called Ervebo and was being used in an experimental phase in the Democratic Republic of Congo.

READ:  Ethiopia, Eritrea Leaders Celebrate Peace And New Year At Border Where War Raged

A who prequalification is granted only after a drug passes important safety and efficacy tests.

The evidence collected during that time the vaccine last year to contain two outbreaks in the Democratic Republic of Congo has convinced regulators that it was safe and effective against Ebola.

READ:  Zimbabwe Doctors Defy Government Ultimatum To End Strike

Now, the who says there is sufficient evidence that shows that the vaccine works.

It means the world now has the first ever drug to prevent Ebola.

READ:  Nigeria's Buhari To Face Political Heavyweight Opponent In Re-election Bid

The government invoked “compassionate protocols” to allow its use while research was still under way. The vaccine will be available in the market from around mid-next year.

Continue Reading

Health News

One Child Dies Of Pneumonia Every 39 Seconds, Agencies Warn

Published

on

By

One Child Dies Of Pneumonia Every 39 Seconds, Agencies Warn

On health issues, six global health charities have said pneumonia kills more children than any other disease, claiming a life every 39 seconds.

United Nations Children’s agency, UNICEF, and five other groups say the disease is a forgotten epidemic. In a joint statement, the charities say 800,000 children died of the preventable lung diseases last year.

READ:  Theresa May Meets Merkel And Macron To Seek Support For New Brexit Delay

They are asking governments to step up investments to counter pneumonia that can be prevented through vaccination, and treated with antibiotics.

The Democratic Republic of the Congo, Ethiopia, India, Nigeria, and Pakistan are among the affected countries.

READ:  Study Finds TB Prevention Course And First-Line Medicines For HIV

Nigeria is the worst affected country, with more than 400 child pneumonia deaths every day.

Continue Reading

Trending

Copyright © 2018 African News Network. All Rights Reserved.

%d bloggers like this: